BioCentury | Sep 8, 2014
Strategy

Parsing Roche's IPF bet

...I Moerae Matrix Inc. MMI-0100 MAP kinase-activated protein kinase 2 (MAPKAPK2; MK2) inhibitor Ph I Pacific Therapeutics Ltd....
BioCentury | Aug 27, 2012
Clinical News

PTL-202: Completed Phase I enrollment

...healthy male volunteers in an open-label, Indian Phase I trial evaluating single doses of PTL-202. Pacific Therapeutics Ltd....
BioCentury | Dec 19, 2011
Financial News

Pacific Therapeutics completes private placement

Pacific Therapeutics Ltd. (CNSX:PT), Vancouver, B.C. Business: Pulmonary Date completed: 12/14/11 Type: Private placement Raised: C$50,000 ($48,840) Shares: 357,142 Price: C$0.14 Shares after offering: 17.7 million WIR Staff Pulmonary...
BioCentury | Dec 5, 2011
Financial News

Pacific Therapeutics proposes private placement

Pacific Therapeutics Ltd. (CNSX:PT), Vancouver, B.C. Business: Pulmonary Date announced: 11/30/11 Type: Private placement To be raised: Up to C$50,000 ($48,224) Shares: 357,142 Price: C$0.14 Shares outstanding prior: 17.3 million WIR Staff Pulmonary...
BioCentury | Nov 21, 2011
Financial News

Pacific Therapeutics financial update

...Pacific began trading on the Canadian National Stock Exchange under the ticker "PT." Pacific Therapeutics Ltd. (CNSX: PT...
BioCentury | Jul 11, 2011
Company News

Global Health Ventures management update

...Drug delivery Hired: Lola Maksumova as SVP and COO, formerly VP of drug development at Pacific Therapeutics Ltd. WIR...
BioCentury | Jun 28, 2010
Company News

Global Health Ventures, Pacific Therapeutics deal

...of chronic occlusive arterial disease of the limbs. Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Pacific Therapeutics Ltd....
Items per page:
1 - 7 of 7
BioCentury | Sep 8, 2014
Strategy

Parsing Roche's IPF bet

...I Moerae Matrix Inc. MMI-0100 MAP kinase-activated protein kinase 2 (MAPKAPK2; MK2) inhibitor Ph I Pacific Therapeutics Ltd....
BioCentury | Aug 27, 2012
Clinical News

PTL-202: Completed Phase I enrollment

...healthy male volunteers in an open-label, Indian Phase I trial evaluating single doses of PTL-202. Pacific Therapeutics Ltd....
BioCentury | Dec 19, 2011
Financial News

Pacific Therapeutics completes private placement

Pacific Therapeutics Ltd. (CNSX:PT), Vancouver, B.C. Business: Pulmonary Date completed: 12/14/11 Type: Private placement Raised: C$50,000 ($48,840) Shares: 357,142 Price: C$0.14 Shares after offering: 17.7 million WIR Staff Pulmonary...
BioCentury | Dec 5, 2011
Financial News

Pacific Therapeutics proposes private placement

Pacific Therapeutics Ltd. (CNSX:PT), Vancouver, B.C. Business: Pulmonary Date announced: 11/30/11 Type: Private placement To be raised: Up to C$50,000 ($48,224) Shares: 357,142 Price: C$0.14 Shares outstanding prior: 17.3 million WIR Staff Pulmonary...
BioCentury | Nov 21, 2011
Financial News

Pacific Therapeutics financial update

...Pacific began trading on the Canadian National Stock Exchange under the ticker "PT." Pacific Therapeutics Ltd. (CNSX: PT...
BioCentury | Jul 11, 2011
Company News

Global Health Ventures management update

...Drug delivery Hired: Lola Maksumova as SVP and COO, formerly VP of drug development at Pacific Therapeutics Ltd. WIR...
BioCentury | Jun 28, 2010
Company News

Global Health Ventures, Pacific Therapeutics deal

...of chronic occlusive arterial disease of the limbs. Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Pacific Therapeutics Ltd....
Items per page:
1 - 7 of 7